This blog tracks updates to the Blood Sugar 101 Web site.

Monday, April 1, 2013

Added New Information to Drug Summary Page

Page Changed: Diabetes Drugs - Quick Summary

Updated information for incretin drugs Byetta, Bydureon, Januvia, Janumet, Onlglyza, Kombiglyze, Trajenta, Jentadueto, and Victoza to include doubled risk of pancreatitis and abnormal cell overgrowth associated with adenomas and tumors.

Added information about Invokana, the new SGLT2 inhibitor.

Changed rating of all incretin drugs to ---- due to convincing evidence that they cause dangerous cell changes in the pancreas.